Cargando…

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

The androgen receptor (AR) is overexpressed and hyperactivated in human castration-resistant prostate cancer (CRPC). However, the determinants of AR overexpression in CRPC are poorly defined. Here we show that retinoid acid receptor-related orphan receptor γ (ROR-γ) is overexpressed and amplified in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Junjian, Zou, June X., Xue, Xiaoqian, Cai, Demin, Zhang, Yan, Duan, Zhijian, Xiang, Qiuping, Yang, Joy C., Louie, Maggie C., Borowsky, Alexander D., Gao, Allen C., Evans, Christopher P., Lam, Kit S., Xu, Jianzhen, Kung, Hsing-Jien, Evans, Ronald M., Xu, Yong, Chen, Hong-Wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030109/ https://www.ncbi.nlm.nih.gov/pubmed/27019329 http://dx.doi.org/10.1038/nm.4070

Ejemplares similares

RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
por: Cai, Demin, et al.
Publicado: (2019)

Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism
por: Shih, Jing-Wen, et al.
Publicado: (2015)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
por: Zheng, Jianwei, et al.
Publicado: (2020)

Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer
por: Hung, Chiu-Lien, et al.
Publicado: (2023)

Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance
por: Wang, Hong, et al.
Publicado: (2022)

Modeling Truncated AR Expression in a Natural Androgen Responsive Environment and Identification of RHOB as a Direct Transcriptional Target
por: Tsai, Hui-Chi, et al.
Publicado: (2012)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
por: Kung, Hsing-Jien
Publicado: (2010)

ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
por: Liu, Dongli, et al.
Publicado: (2020)

Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
por: Zhang, Xiong, et al.
Publicado: (2021)

Predicting castration-resistant prostate cancer after combined androgen blockade
por: He, Miao, et al.
Publicado: (2017)

Prognostic value of lncRNA ROR expression in various cancers: a meta-analysis
por: Lu, Renfu, et al.
Publicado: (2018)

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
por: Gunter, Jennifer H., et al.
Publicado: (2012)

Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer
por: Harshman, Lauren C., et al.
Publicado: (2013)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer
por: Li, Qi, et al.
Publicado: (2019)

The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
por: Parolia, Abhijit, et al.
Publicado: (2019)

Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
por: Liu, Dongli, et al.
Publicado: (2022)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Persistent androgen receptor addiction in castration-resistant prostate cancer
por: Schweizer, Michael T., et al.
Publicado: (2015)

The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
por: Feng, Qin, et al.
Publicado: (2019)

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

SUMO and KSHV Replication
por: Chang, Pei-Ching, et al.
Publicado: (2014)

Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena
por: Shih, Jing-Wen, et al.
Publicado: (2017)

Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature
por: Wang, Junjian, et al.
Publicado: (2015)

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer
por: Titus, Mark A., et al.
Publicado: (2012)

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
por: Decker, Keith F., et al.
Publicado: (2012)

Possible mechanism of benign prostatic hyperplasia induced by androgen–estrogen ratios in castrated rats
por: Xiang-Yun, Liu, et al.
Publicado: (2010)

Spindle pole body component 25 in the androgen-induced regression of castration-resistant prostate cancer
por: Cui, Feilun, et al.
Publicado: (2022)

Castration delays epigenetic aging and feminizes DNA methylation at androgen-regulated loci
por: Sugrue, Victoria J, et al.
Publicado: (2021)

Targeting molecular resistance in castration-resistant prostate cancer
por: Chandrasekar, Thenappan, et al.
Publicado: (2015)

Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
por: Chandrasekar, Thenappan, et al.
Publicado: (2015)

Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
por: Uo, Takuma, et al.
Publicado: (2020)

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2018)

Long Non-Coding RNA and Epigenetic Gene Regulation of KSHV
por: Campbell, Mel, et al.
Publicado: (2014)

HMGB1 promotes the development of castration-resistant prostate cancer by regulating androgen receptor activation
por: Chen, Junyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gvb3crp5g3oh1gj6c46kmevg3